Abstract:Objective To investigate the application value of neuron-specific enolase (NSE) and lactate levels in assessing the severity of myocardial injury following neonatal asphyxia.Method A retrospective analysis was conducted on 120 neonates with asphyxia and associated myocardial injury treated at Changzhou Maternal and Child Health Care Hospital from October 2020 to October 2023. Based on the levels of cardiac troponin I (cTnI), a myocardial injury biomarker, patients were divided into a mild group (79 cases) and a severe group (41 cases). Additionally, 60 healthy neonates born during the same period served as the control group. Serum levels of NSE, lactate, brain natriuretic peptide, and lactate dehydrogenase were compared among the three groups. Spearman's correlation analysis was used to examine the relationship between serum NSE, lactate, and myocardial injury markers. Receiver operating characteristic (ROC) curves were drawn to analyze the diagnostic value of these indicators in assessing the severity of myocardial injury in neonates with asphyxia.Result The levels of NSE and lactate were higher in the severe group compared to the mild and control groups (P <0.05), and also higher in the mild group compared to the control group (P <0.05). NSE showed positive correlations with cTnI, brain natriuretic peptide, and lactate dehydrogenase (rs = 0.604, 0.596, and 0.631, respectively, all P <0.05). Lactate also showed positive correlations with these myocardial injury markers (rs = 0.748, 0.666, and 0.738, respectively, all P <0.05). NSE and lactate demonstrated high sensitivity [95.1% (95% CI: 0.835, 0.994)] and specificity [93.7% (95% CI: 0.858, 0.979)] in diagnosing the severity of myocardial injury.Conclusion NSE and lactate can serve as effective biomarkers for assessing the severity of myocardial injury following neonatal asphyxia, aiding clinicians in early risk assessment and in devising appropriate treatment strategies.